This website is intended for UK healthcare professionals only Log in | Register

Tag Archives: apps

June 2020

COVID-19 and smartphone apps

Madeleine Oliver

Abstract

Table 1. Where to find the apps Microguide Apple AppStore: https://apps.apple.com/gb/app/microguide/id447171786 Google Play Store: https://play.google.com/store/apps/details?id=com.xancu.utreat&hl=en_GB UpToDate Apple App Store: https://apps.apple.com/gb/app/uptodate/id334265345 Google Play Store: https://play.google.com/store/apps/details?id=com.uptodate.android&hl=en_GB Timed Walk Apple AppStore: https://apps.apple.com/app/id1515893887 GooglePlayStore: https://play.google.com/store/apps/details?id=se.mau.iotap.timedwalkapp Nye Health Apple App Store: https://apps.apple.com/gb/app/nye-health/id1439306034 Google Play

| Full text
News from the Cardiorenal Forum 12th Annual Scientific Meeting – Improving treatments in cardiorenal patients

March 2018

News from the Cardiorenal Forum 12th Annual Scientific Meeting – Improving treatments in cardiorenal patients

Fazlullah Wardak and Rosie Kalsi

Abstract

Do new diabetes drugs protect the heart and kidney? The day’s keynote session was given by Professor Johannes Mann (Friedrich Alexander University of Erlangen, Germany). Diabetes management has been transformed with the introduction of newer agents with the promise of cardiovascular and renal protection. The sodium glucose co-transporter-2 (SGLT-2) inhibitors are known to reduce the hyperfiltration, which occurs in early diabetic nephropathy. Glucagon-like peptide 1 (GLP-1) receptor agonists are incretin mimetics, which have several benefits for diabetes management. The mechanisms by which GLP-1 agonist therapy may reduce blood pressur

| Full text
Cardiovascular applications: <br>apps – a beginner’s guide

July 2016 Br J Cardiol 2016;23:100 Online First

Cardiovascular applications:
apps – a beginner’s guide

Jonathan Bennett

Abstract

Introduction Jonathan Bennett (FY2 Doctor, London) In less than a decade since the first iPhone, smartphone technology has become more powerful and portable. The opportunity to become more connected to friends, family and information has been nearly universally embraced. The ability of the smartphone has not been underestimated, and the development of the mobile health (mHealth) industry has been rapid.1 The approval of iECG2 for mobile patient-lead telemetry, the Dexcom cutaneous blood glucose monitoring3 and most recently the Proteus Digital ingestible sensor to promote medication adherence4 prove, not only how powerful the technology is, b

| Full text

For healthcare professionals only

Add Banner

Close

You are not logged in

You need to be a member to print this page.
Find out more about our membership benefits

Register Now Already a member? Login now
Close

You are not logged in

You need to be a member to download PDF's.
Find out more about our membership benefits

Register Now Already a member? Login now